NEW YORK, June 9, 2025 /PRNewswire/ -- Formation Bio, an AI-driven pharmaceutical company focused on accelerating drug development, today announced the appointment of its first class of Entrepreneurs ...

NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Formation Bio and Jiangsu Chia Tai Feng Hai Pharmaceutical Co., LTD. (CTFH) today announced Formation Bio's acquisition of worldwide rights, excluding Greater ...

Formation Bio Inc., a startup using artificial intelligence to speed up drug development, today announced that it has closed a mammoth $372 million investment. Andreessen Horowitz led the Series D ...

Add Yahoo as a preferred source to see more of our stories on Google. Canadian PM Trudeau tours a Sanofi facility in Toronto (Reuters) - AI-based drug developer Formation Bio said on Wednesday that it ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors ...

Formation Bio CEO Benjamine Liu joins 'Fast Money' as Formation comes in at #37 on the Disruptor 50 list. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get ...

Former Pfizer, BenevolentAI, Incyte, and AMAG executives join to strengthen clinical, technology, financial, and scientific leadership as company scales its AI-native pharma model NEW YORK, Sept. 18, ...

Formation Bio partners, acquires, or in-licenses drugs from pharma companies and biotechs to develop programs past clinical proof of concept and beyond, leveraging their proprietary tech and AI ...

(RTTNews) - French drug major Sanofi (SNYNF, SNY) announced Tuesday a collaboration with Formation Bio and AI research and deployment company OpenAI to build AI-powered software to accelerate drug ...

(Reuters) - AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi. The ...